INTELLIGENT BIO SOLUTIONS INC. current report, 21 December 2022

Business Context and Reporting Period

This Form 8-K is a current report filed by Intelligent Bio Solutions Inc. on December 21, 2022. The filing addresses corporate governance matters, specifically the scheduling of the Annual Meeting of Stockholders for the fiscal year ended June 30, 2022 (FY22), and the cancellation of the previously adjourned FY21 Annual Meeting.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder meeting logistics and does not contain financial performance data.

Material Changes

  • Meeting Cancellation: The Board of Directors cancelled the FY21 Annual Meeting, which had been adjourned multiple times due to a lack of quorum.
  • Meeting Scheduling: The FY22 Annual Meeting is scheduled to be held virtually on or about February 8, 2023.
  • Record Date: Stockholders of record as of the close of business on January 3, 2023, are entitled to vote at the FY22 Annual Meeting.

Guidance, Outlook, and Risks

The filing does not contain financial guidance, management commentary on business outlook, or specific risk factors beyond the operational challenge of achieving a quorum for the previous meeting. The primary focus is on compliance with Rule 14a-8 under the Exchange Act regarding shareholder proposals.

Deadlines for Proposals: To be considered for inclusion in the FY22 proxy statement, shareholder proposals and director nominations must be received by the Company Secretary no later than the close of business on December 31, 2022.

Key Facts for Investor Verification

  • Verify the exact date and time of the FY22 Annual Meeting once the official notice and proxy statement are released.
  • Confirm the record date of January 3, 2023, to ensure eligibility to vote.
  • Note the strict December 31, 2022, deadline for submitting shareholder proposals or director nominations for the upcoming meeting.
  • Review the press release (Exhibit 99.1) for additional context on the cancellation of the FY21 meeting.